Rochester Medical Corp
(NASDAQ: ROCM)
-0.05
-0.34%
| Exchange: | NASDAQ |
| Stock: | Rochester Medical Corp |
| Industry: | NA |
| Employees: | 344 |
| Rochester Medical Corporation develops, manufactures and markets a range of polyvinyl chloride (PVC)-free and latex-free urinary continence and urine drainage care products for the extended care and acute care markets. The Company’s extended care products include a range of male external catheters (MECs) for managing male urinary incontinence and a range of intermittent catheters for managing both male and female urinary retention. It also sells a range of latex male external catheters in the United Kingdom. Its Magic3 is a range of silicone intermittent catheters. Its extended care products also include the FemSoft Insert, a soft, liquid-filled, conformable urethral insert for managing female stress urinary incontinence in adult females. Its acute care products include a range of standard Foley catheters, Strata brand of Foley catheters, and Strata-NF Catheter, an antibacterial Foley catheter that reduces the incidence of hospital acquired urinary tract infection (UTI). |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
